{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"5.390","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"220,094,500","primaryexch":"HKEX","ric":"9989.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.4408,"inline_upper_strike_price":"","sedol":"BMFR225","am":"13.58","iv":"","ew_strike":"","as":"5.310","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"5.300","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-26 10:38:37.0","lo52":"3.200","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Li Li","underlying_ric":"002399.SZ","hi52":"7.260","issuer_name":"Shenzhen Hepalink Pharmaceutical Group Co., Ltd. - H Shares","h_share_flag":true,"ew_sub_per_from":"","div_yield":"5.12","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"5.290","mkt_cap":"1.16","f_aum_hkd":null,"ew_sub_per_to":"","ls":"5.310","nav_date":"","csic_classification":"Health Care","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.080","aum":"","issued_shares_class_B":null,"vo":"2.55","secondary_listing_flag":false,"listing_date":"8 Jul 2020","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Shenzhen Hepalink Pharmaceutical Group Co., Ltd. - H Shares","nm_s":"HEPALINK","sym":"9989","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based pharmaceutical company focused on the field of heparin sodium preparations and raw materials, macromolecular drugs contract development manufacturing organization (CDMO) and innovative drug development. The Companyâ€™s main products and services include enoxaparin sodium preparations and heparin sodium bulk medicines, enoxaparin sodium bulk medicines, and CDMO services for macromolecular drugs. The Company distributes its products within the domestic market and to overseas markets, including Turkey, Brazil, the United States and others.","op":"5.360","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"No.21 Langshan Road<br/>Nanshan District<br/>Shenzhen<br/>PRC","pc":"-1.48","days_to_expiry":null,"underlying_code":null,"pe":"11.39","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"5.390","isin":"CNE100003YN2","moneyness":""}},"qid":"1758890365793"}
